研究概要

主要論文

• 1. Matsumoto K., Okuyama K., Sidwell T., Yamashita M., Endo T., Satoh-Takayama N., Ohno H., Morio T., Rothenberg EV., and Taniuchi I.:
  "A Bacl11b N797/K variant isolated from an immunodeficient patient inhibits early thymocyte development in mice."
  Frontiers in Immunology. 2024. Doi: 10.3389/fimmu.2024.1363704.
• 2. Mori A., Ohno H. and Satoh-Takayama N.:
  "Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells."
  Seminars in Immunology. 2024. Doi: 10.1007/s00281-024-01000-1
• 3. Ito A., Akama Y., Satoh-Takayama N., Saito K., Kato T., Kawamoto E., Gaowa A., Park EJ., Takao M., Shimaoka M.:
  "Possible metastatic stage-dependent ILC2 activation induces differential function of MDSCs through IL-13/IL-13Ra1 signaling during the progression of breast cancer lung metastasis."
  Cancers. 14(13): 3267, 2022. doi:10.3390/cancers14133267.
• 4. Shi Z., Takeuchi T., Nakanishi Y., Kato T., Beck K., Nagata R., Kageyama T., Ito A., Ohno H. and Satoh-Takayama N.:
  "A Japanese Herbal formula, Daikenchuto, alleviates experimental colitis by reshaping microbial profiling and enhancing group 3 innate lymphoid cells."
  Frontiers in Immunology. 13: 903459, 2022. doi:10.3389/fimmu.2022.903459.
• 5. Akama Y., Park EJ., Satoh-Takayama N., Gaowa A., Ito A., Kawamoto E., Darkwas S., Appiah M.G., Myint PK., Ohno H., Imai H. and Shimaoka M.:
  "Sepsis induces deregulation of IL-13 production and PD-1 expression in lung group 2 innate lymphoid cells."
  Shock. 55: 357-370, 2021. doi: 10.1097/SHK.0000000000001647.
• 6. Satoh-Takayama N., Kato T., Motomura Y., Kageyama T., Taguchi-Atarashi N., Daitoku-Kinoshita R., Kuroda E., Di Santo JP., Mimuro H., Moro K. and Ohno H.:
  "Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA."
  Immunity. 52: 635-649, 2020. doi:10.1016/j.immuni.2020.03.002.
• 7. Satoh-Takayama N., Serafini N., Verrier T., Rekiki A., Renauld JC. Frankel G. and Di Santo JP.:
  "CXCR6 controls the functional topography of IL-22 producing intestinal innate lymphoid cells."
  Immunity. 41: 776-788, 2014. doi:10.1016/j.immuni.2014.10.007.
• 8. Satoh-Takayama N., Lesjean-Pottier S., Sawa S,. Vosshenrich CA., Eberl G. and Di Santo JP.:
  "Lymphotoxin-beta receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells."
  European Journal of Immunology. 41: 780-6, 2011. doi:10.1002/eji.201040851.
• 9. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich CA. and Di Santo JP.:
  "IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subset from Id2-dependent precursors."
  Journal of Experimental Medicine. 207: 273-80, 2010. doi:10.1084/jem.20092029.
• 10. Satoh-Takayama N., Vosshenrich CA., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention JJ., Thiam K., Cerf-Bensussan N., Mandelboim O., Eberl G. and Di Santo JP.
  "Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense."
  Immunity. 29: 958-70, 2008. doi:10.1016/j.immuni.2008.11.001.

イベント･シンポジウムなど

関連リンク

メンバーリスト

お問い合わせ先